TherapeuticsMD Inc
NASDAQ:TXMD

Watchlist Manager
TherapeuticsMD Inc Logo
TherapeuticsMD Inc
NASDAQ:TXMD
Watchlist
Price: 2.13 USD -2.29%
Updated: May 31, 2024

TherapeuticsMD Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

TherapeuticsMD Inc
Income from Continuing Operations Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
TherapeuticsMD Inc
NASDAQ:TXMD
Income from Continuing Operations
-$6.2m
CAGR 3-Years
67%
CAGR 5-Years
47%
CAGR 10-Years
15%
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$17.1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
-$254m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$2.3B
CAGR 3-Years
-22%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
5%

See Also

What is TherapeuticsMD Inc's Income from Continuing Operations?
Income from Continuing Operations
-6.2m USD

Based on the financial report for Mar 31, 2024, TherapeuticsMD Inc's Income from Continuing Operations amounts to -6.2m USD.

What is TherapeuticsMD Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%

Over the last year, the Income from Continuing Operations growth was 90%. The average annual Income from Continuing Operations growth rates for TherapeuticsMD Inc have been 67% over the past three years , 47% over the past five years , and 15% over the past ten years .